CoreRx, Inc. Announces New Expanded Capabilities
Tampa, FL, May 12, 2007 --(PR.com)-- CoreRx, Inc. is an American owned company located in Tampa, Florida.
CoreRx, Inc. announces the expansion of it’s capabilities including DEA licensure for controlled substances. This gives CoreRx, Inc. the ability to work with DEA schedule 2-5 active pharmaceutical ingredients and drug products. CoreRx also announces the addition of stability storage chambers at four ICH guideline storage conditions of 4°C, 25°C/60%R.H., 30°C/65%R.H. and 40°C/75%R.H. The stability chambers will enable CoreRx, Inc. to offer both non-GMP and GMP stability study capabilities to their clients.
CoreRx, Inc. Director of Analytical and Pre-Formulation Development, Dr. Todd Daviau stated “with these expanded capabilities we are able to add to the services we offer our clients. In the nine-months since the inception of CoreRx, Inc. we have added necessary capabilities to meet the needs of our clients on a timely and efficient basis. Daviau also stated “we will acquire whatever equipment or technology is necessary to meet the needs of our client’s demands.”
The principal owners of CoreRx, Inc. average more than 15 years of pharmaceutical development experience each. Their expertise has enabled clients to realize an advantage and capitalize on the burgeoning pharmaceutical market over the last several years. CoreRx has the capabilities for developing all dosage forms (tablets, capsules, liquids, gels, creams, parenterals, ophthalmics, etc.) in meeting the needs of the clients in the pharmaceutical industry.
CoreRx™ focuses on supporting and streamlining the drug development process for biotechnology and pharmaceutical innovators by offering services such as pre-formulation/formulation development, analytical development, clinical manufacturing and validation engineering. They have a proven track record and extensive expertise providing comprehensive drug development services to biotechnology and pharmaceutical companies worldwide.
At CoreRx™ they maintain open communications with their clients, so that they can provide innovative solutions on budget while maintaining their core values of quality, integrity, and efficiency.
The facility is conveniently located in Tampa, Florida, a few miles from the Tampa International Airport. For more information, visit their website at www.corerxpharma.com or call (813) 514-9399.
###
CoreRx, Inc. announces the expansion of it’s capabilities including DEA licensure for controlled substances. This gives CoreRx, Inc. the ability to work with DEA schedule 2-5 active pharmaceutical ingredients and drug products. CoreRx also announces the addition of stability storage chambers at four ICH guideline storage conditions of 4°C, 25°C/60%R.H., 30°C/65%R.H. and 40°C/75%R.H. The stability chambers will enable CoreRx, Inc. to offer both non-GMP and GMP stability study capabilities to their clients.
CoreRx, Inc. Director of Analytical and Pre-Formulation Development, Dr. Todd Daviau stated “with these expanded capabilities we are able to add to the services we offer our clients. In the nine-months since the inception of CoreRx, Inc. we have added necessary capabilities to meet the needs of our clients on a timely and efficient basis. Daviau also stated “we will acquire whatever equipment or technology is necessary to meet the needs of our client’s demands.”
The principal owners of CoreRx, Inc. average more than 15 years of pharmaceutical development experience each. Their expertise has enabled clients to realize an advantage and capitalize on the burgeoning pharmaceutical market over the last several years. CoreRx has the capabilities for developing all dosage forms (tablets, capsules, liquids, gels, creams, parenterals, ophthalmics, etc.) in meeting the needs of the clients in the pharmaceutical industry.
CoreRx™ focuses on supporting and streamlining the drug development process for biotechnology and pharmaceutical innovators by offering services such as pre-formulation/formulation development, analytical development, clinical manufacturing and validation engineering. They have a proven track record and extensive expertise providing comprehensive drug development services to biotechnology and pharmaceutical companies worldwide.
At CoreRx™ they maintain open communications with their clients, so that they can provide innovative solutions on budget while maintaining their core values of quality, integrity, and efficiency.
The facility is conveniently located in Tampa, Florida, a few miles from the Tampa International Airport. For more information, visit their website at www.corerxpharma.com or call (813) 514-9399.
###
Contact
CoreRx, Inc.
Brian McMillan
813 514 9399
www.corerxpharma.com
Brian McMillan
813 514 9399
www.corerxpharma.com
Contact
Categories